Pharmaceuticals

American Appraisal provides valuation and consulting services to some of the world’s leading pharmaceutical firms.

Who We Serve
American Appraisal serves US and international companies operating in all niches of the pharmaceuticals industry, including:

• Companies researching new treatment techniques
• Developers and manufacturers of proprietary drugs
• Manufacturers of generic equivalents
• Manufacturers and marketers of over-the-counter products
• Companies manufacturing animal nutrition and care products

What We Do
We provide valution expertise in all classifications of tangible and intangible assets, including the following:

Our valuation and consulting services for our clients in the pharmaceuticals industry encompass:

• Purchase price allocations for financial reporting purposes (US GAAP and IFRS)
• US and international tax reporting
• Impairment testing
• Transfer pricing analyses
• Bankruptcy and restructuring valuations
• Fresh start accounting
• Equity and option valuations
• Real estate advisory
• Real and personal property tax valuations and negotiations
• Fixed asset inventory and reconciliation
• IT asset inventory
• Cost segregation studies
• Property insurance appraisals
• Sale and purchase negotiations

Recent Experience
American Appraisal’s recent experience includes the following:

• Providing IFRS 3 consulting and allocation services for a European pharmaceutical company in its multibillion-dollar acquisition of a US biotech company
• Insurance appraisal services for a leading pharmaceutical research company
• Valuations of real estate and equipment located in Ireland and Puerto Rico for a Canadian pharmaceuticals company
• Valuation of a large pharmaceuticals production facility for disposal
• Property tax valuation for a large Midwest and East Coast pharmaceuticals chemical production and packaging operation and its associated R&D facilities

Why American Appraisal?
American Appraisal is a leader in the valuation of intangible assets, making us well prepared to serve the pharmaceuticals industry and its many associated intangibles such as IPR&D, patents and patent applications. Our global valuation team is well positioned to assist clients with their US and international valuation requirements.